Recently, it has been reported that luteolin can increase the degradation of YAP protein, thereby inhibiting epithelial mesenchymal transition and breast cancer cell migration (Cao et al., 2020), of which are implicated that luteolin may ameliorates pulmonary arterial hypertension via suppressing Hippo-YAP/PI3K/AKT signaling pathway. The gene discussed is YAP1; the disease is breast carcinoma.